...AlloVir. Giroir has been a board member of biomedical companies BrainCheck Inc. (Houston, Texas) and Esperance Pharmaceuticals Inc....
...Health in Dallas; and professor at the University of Texas Southwestern Medical Center. Steve Usdin, Washington Editor AlloVir Esperance Pharmaceuticals Inc. Texas...

...paclitaxel led to an ORR, the primary endpoint, of 34.8% vs. 33.3% for paclitaxel alone. Esperance...
...>3 months. Data were presented at the American Society of Clinical Oncology meeting in Chicago. Esperance Pharmaceuticals Inc....

...and an undisclosed amount in June 2011 in a series B round for cancer play Esperance Pharmaceuticals Inc....

...with Cancer Research Technology Ltd. to develop ADCs. A third company developing improved payloads is Esperance Pharmaceuticals Inc....
...N.J. City of Hope , Duarte, Calif. Endo Health Solutions Inc. (NASDAQ:ENDP), Chadds Ford, Pa. Esperance Pharmaceuticals Inc....
...a mAb Preclin Improved payloads ADC Therapeutics S.a.r.l. Pyrrolobenzodiazepine (PDB) payloads that cross-link DNA Preclin Esperance Pharmaceuticals Inc....

...month, Esperance began the Phase II ESP2011-002 trial of EP-100 to treat advanced ovarian cancer. Esperance Pharmaceuticals Inc....

...includes a run-in period in 5-8 patients to confirm the maximum safe dose of EP-100. Esperance Pharmaceuticals Inc....

...Fund; Themelios Ventures Partners; Research Corp. Technologies; Advantage Capital Partners; existing investors; new investors Note: Esperance...